BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

614 related articles for article (PubMed ID: 18977585)

  • 21. Drooling: are botulinum toxin injections into the major salivary glands a good treatment option?
    Nordgarden H; Østerhus I; Møystad A; Asten P; Johnsen UL; Storhaug K; Loven JØ
    J Child Neurol; 2012 Apr; 27(4):458-64. PubMed ID: 21940695
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Factors in the Efficacy, Safety, and Impact on Quality of Life for Treatment of Drooling with Botulinum Toxin Type A in Patients with Cerebral Palsy.
    Gonzalez-L MD; Martinez C; Bori Y Fortuny I; Suso-Vergara S
    Am J Phys Med Rehabil; 2017 Feb; 96(2):68-76. PubMed ID: 28099276
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The efficacy of botulinum toxin-A in the treatment of hypersalivation in children with cerebral palsy].
    Alataş N; Yazgan P; Oztürk A; San I
    Kulak Burun Bogaz Ihtis Derg; 2006; 16(2):49-53. PubMed ID: 16763416
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Does motor performance matter in botulinum toxin efficacy for drooling?
    Erasmus CE; Scheffer AR; van Hulst K; van Limbeek J; van den Hoogen FJ; Rotteveel JJ; Jongerius PH
    Pediatr Neurol; 2011 Aug; 45(2):95-9. PubMed ID: 21763949
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reduction of salivary flow with botulinum toxin: extended report on 33 patients with drooling, salivary fistulas, and sialadenitis.
    Ellies M; Gottstein U; Rohrbach-Volland S; Arglebe C; Laskawi R
    Laryngoscope; 2004 Oct; 114(10):1856-60. PubMed ID: 15454785
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A double-blind placebo-controlled trial of botulinum toxin B for sialorrhea in Parkinson's disease.
    Ondo WG; Hunter C; Moore W
    Neurology; 2004 Jan; 62(1):37-40. PubMed ID: 14718694
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical study of botulinum-A toxin in the treatment of sialorrhea in children with cerebral palsy.
    Suskind DL; Tilton A
    Laryngoscope; 2002 Jan; 112(1):73-81. PubMed ID: 11802042
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Botulinum toxin injections for children with excessive drooling.
    Hassin-Baer S; Scheuer E; Buchman AS; Jacobson I; Ben-Zeev B
    J Child Neurol; 2005 Feb; 20(2):120-3. PubMed ID: 15794177
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Botulinum toxin is a useful treatment in excessive drooling in saliva.
    Bhatia KP; Münchau A; Brown P
    J Neurol Neurosurg Psychiatry; 1999 Nov; 67(5):697. PubMed ID: 10577041
    [No Abstract]   [Full Text] [Related]  

  • 30. Successful management of drooling with botulinum toxin A in neurologically disabled children.
    Ellies M; Rohrbach-Volland S; Arglebe C; Wilken B; Laskawi R; Hanefeld F
    Neuropediatrics; 2002 Dec; 33(6):327-30. PubMed ID: 12571790
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of botulinum toxin injection for achalasia in Thai patients.
    Leelakusolvong S; Sinpeng T; Pongprasobchai S; Tanwandee T; Kachintorn U; Manatsathit S
    J Med Assoc Thai; 2006 Nov; 89 Suppl 5():S67-72. PubMed ID: 17718248
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Two-year placebo-controlled trial of botulinum toxin A for leg spasticity in cerebral palsy.
    Moore AP; Ade-Hall RA; Smith CT; Rosenbloom L; Walsh HP; Mohamed K; Williamson PR
    Neurology; 2008 Jul; 71(2):122-8. PubMed ID: 18606966
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Botulinum toxin type B for sialorrhea in children with cerebral palsy.
    Reddihough D; Graham HK
    Dev Med Child Neurol; 2011 Jun; 53(6):488-9. PubMed ID: 21501158
    [No Abstract]   [Full Text] [Related]  

  • 34. [Experiences with botulinum toxin injections against spasticity in children].
    Ramstad K; Karstensen AB; Risberg K; Bergsaker DK; Sommer FF
    Tidsskr Nor Laegeforen; 2006 Feb; 126(4):450-2. PubMed ID: 16477283
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drooling in cerebral palsy: hypersalivation or dysfunctional oral motor control?
    Erasmus CE; Van Hulst K; Rotteveel LJ; Jongerius PH; Van Den Hoogen FJ; Roeleveld N; Rotteveel JJ
    Dev Med Child Neurol; 2009 Jun; 51(6):454-9. PubMed ID: 19207297
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical prevalence of drooling in infant cerebral palsy.
    Morales Chávez MC; Nualart Grollmus ZC; Silvestre-Donat FJ
    Med Oral Patol Oral Cir Bucal; 2008 Jan; 13(1):E22-6. PubMed ID: 18167475
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Botulinum A toxins in the treatment of spasticity in cerebral palsy during childhood].
    García Ruiz PJ; Sánchez Bernardos V; Urcelay V; San Martín V; Castillo F; Ferrer A; Campos J; García de Yébeñes J
    Neurologia; 1996 Jan; 11(1):34-6. PubMed ID: 8714175
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after stroke.
    Jahangir AW; Tan HJ; Norlinah MI; Nafisah WY; Ramesh S; Hamidon BB; Raymond AA
    Med J Malaysia; 2007 Oct; 62(4):319-22. PubMed ID: 18551937
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Salivary gland application of botulinum toxin for the treatment of sialorrhea.
    Fuster Torres MA; Berini Aytés L; Gay Escoda C
    Med Oral Patol Oral Cir Bucal; 2007 Nov; 12(7):E511-7. PubMed ID: 17978775
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Randomized double-blind study of botulinum toxin type B for sialorrhea in ALS patients.
    Jackson CE; Gronseth G; Rosenfeld J; Barohn RJ; Dubinsky R; Simpson CB; McVey A; Kittrell PP; King R; Herbelin L;
    Muscle Nerve; 2009 Feb; 39(2):137-43. PubMed ID: 19145653
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.